About UO Ematologia e CTMO di Piacenza
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Fondazione Italiana Linfomi ONLUS
2
Clinical Trials at UO Ematologia e CTMO di Piacenza
During the past decade, UO Ematologia e CTMO di Piacenza conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study Investigating the Cardiotoxicity of Anthracyclines in Patients With Diffuse Large B-Cell
2014-02-12
2031-02-01
Active, not recruiting
127
Prephase Treatment With Prednisone +/- Vitamin D Supplementation Followed by Immunochemotherapy
2021-03-23
2030-09-01
Recruiting
430
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "UO Ematologia e CTMO di Piacenza"
#1 collaborator was "GRADE Onlus" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at UO Ematologia e CTMO di Piacenza
According to Clinical.Site data, the most researched conditions in "UO Ematologia e CTMO di Piacenza" are
"Diffuse Large B-Cell" (1 trials), "Diffuse Large B-Cell Lymphoma" (1 trials), "Elderly Patients" (1 trials), "Large B-Cell" (1 trials) and "Lymphoma" (1 trials). Many other conditions were trialed in "UO Ematologia e CTMO di Piacenza" in a lesser frequency.
Clinical Trials Intervention Types at UO Ematologia e CTMO di Piacenza
Most popular intervention types in "UO Ematologia e CTMO di Piacenza" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "R-CHOP with doxorubicin" (1 trials), "RCHOP o R-miniCHOP at standard doses" (1 trials) and "Vitamin D3 (Cholecalciferol)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at UO Ematologia e CTMO di Piacenza
The vast majority of trials in "UO Ematologia e CTMO di Piacenza" are
2 trials for "All" genders.
Clinical Trials Status at UO Ematologia e CTMO di Piacenza
Currently, there are NaN active trials in "UO Ematologia e CTMO di Piacenza".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in UO Ematologia e CTMO di Piacenza,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in UO Ematologia e CTMO di Piacenza, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".